基于世界胃肠病学大会提议的HBV相关慢加急性肝衰竭的临床特征及分型探讨

徐天娇; 吕飒; 游绍莉; 田华; 王海波; 宋芳娇; 朱冰

doi:10.3969/j.issn.1001-5256.2018.03.020

基于世界胃肠病学大会提议的HBV相关慢加急性肝衰竭的临床特征及分型探讨

DOI: 10.3969/j.issn.1001-5256.2018.03.020

解放军第三○二医院肝衰竭诊疗与研究中心

基金项目:

军队优秀青年科技人才扶持对象项目；国家“十三五”科技重大专项(2017ZX10203201-004)；

详细信息

中图分类号: R512.62;R575.3
计量
- 文章访问数: 1569
- HTML全文浏览量: 19
- PDF下载量: 423
- 被引次数: 0
出版历程
- 出版日期: 2018-03-20

Clinical features and typing of hepatitis B virus-related acute-on-chronic liver failure based on recommendations of the World Congress of Gastroenterology

Liver Failure Treatment and Research Center, 302 Hospital of PLA

Research funding:

摘要

摘要:
目的探讨不同分型的HBV相关慢加急性肝衰竭患者临床特征及预后情况。方法回顾性分析解放军第三○二医院2016年1月-2016年12月收治的296例基于世界胃肠病学大会提议的HBV相关慢加急性肝衰竭患者的临床资料,根据发病基础分为A型（慢性肝炎组,n=53）、B型（代偿期肝硬化组,n=151）、C型（失代偿期肝硬化组,n=92）。对3组患者的实验室指标、合并症发生率及预后进行分析。多组间计量资料比较服从正态分布且方差齐的采用方差分析,进一步两两比较采用LSD-t检验,不服从正态分布或方差不齐的采用Kruskal-Wallis H检验;计数资料比较采用Pearsonχ2检验。结果 3组间Alb、ALT、胆碱酯酶（Ch E）及AFP水平两两比较差异均有统计学意义（P值均<0.05）,A型最高,其次是B型,C型最低;对于AST、PLT,A型最高,分别与B型和C型两两比较,差异均有统计学意义（P值均<0.05）。对于总胆固醇（TCHO）,A型和B型患者均高于C型患者（P值均<0.05）。腹水或胸水（69.81%vs 88.08%vs 90.22%）、肝肾综合...
- 肝功能衰竭 /
- 肝炎病毒,乙型 /
- 世界胃肠病学大会
Abstract:
Objective To investigate the clinical features and prognosis of patients with different types of hepatitis B virus-related acute-on-chronic liver failure ( HBV-ACLF) . Methods A retrospective analysis was performed for the clinical data of 296 patients with HBV-ACLF who were admitted to 302 Hospital of PLA from January to December, 2016 and diagnosed based on recommendations of the World Congress of Gastroenterology, and according to the pathogenesis, these patients were divided into chronic hepatitis group ( type A group with 53 patients) , compensated cirrhosis group ( type B group with 151 patients) , and decompensated cirrhosis group ( type C group with 92 patients) . Laboratory markers, incidence of comorbidities, and prognosis were analyzed for all groups. An analysis of variance was used for comparison of normally distributed continuous data with homogeneity of variance between multiple groups, and the least significant difference t-test was used for further comparison between two groups; the Kruskal-Wallis H test was used for comparison of non-normally distributed continuous data or continuous data with heterogeneity of variance between groups. The Pearson's chi-square test was used for comparison of categorical data between groups. Results There were significant differences in albumin, alanine aminotransferase, and cholinesterase between the three groups ( all P < 0. 05) , and the type A group had the highest levels, followed by the type B group and the type C group.The type A group had significantly higher levels of aspartate aminotransferase and platelet count than the type B group and the type C group ( all P < 0. 05) . The type A group and the type B group had a significantly higher level of total cholesterol than the type C group ( both P<0. 05) . Compared with the type A group and the type B group, the type C group had significantly higher incidence rates of ascites/pleural effusion ( 90. 22% vs 69. 81%/88. 08%, χ2= 12. 964, P < 0. 05) and hepatorenal syndrome ( 43. 48% vs 18. 87%/28. 48%, χ2= 10. 691, P < 0. 05) . The type B group and type C group had a significantly higher incidence rate of peritonitis than the type A group ( 40. 40%/48. 91% vs 22. 64%, χ2= 9. 718, P < 0. 05) . There was a significant difference in improvement rate between the three groups ( 52. 83% vs 45. 70% vs 32. 61%, χ2= 6. 593, P < 0. 05) . Conclusion There are significant differences in biochemical parameters, comorbidities, and prognosis between HBV-ACLF patients with HBV-related chronic hepatitis, compensated cirrhosis, and decompensated cirrhosis.Such a typing method helps to explore treatment measures and assess prognosis.
- liver failure /
- hepatitis B virus /
- World Congress of Gastroenterology

HTML全文

参考文献(19)

[1]YOU S, RONG Y, ZHU B, et al.Changing etiology of liver failure in 3, 916 patients from northern China:a 10-year survey[J].Hepatol Int, 2013, 7 (2) :714-720.

[2]MOREAU R, JALAN R, GINES P, et al.Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis[J].Gastroenterology, 2013, 144 (7) :1426-1437.

[3] Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association.Diagnostic and treatment guidelines for liver failure (2012 version) [J].Chin J Clin Infect Dis, 2012, 5 (6) :321-327. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南 (2012年版) [J].中华临床感染病杂志, 2012, 5 (6) :321-327.

[4]FU SJ, GAO GS, HU AR, et al.Short-term prognostic value of serum procalcitonin and common inflammation markers combined with CTP score in patients with acute-on-chronic liver failure[J].Chin J Pract Intern Med, 2015, 35 (6) :519-521. (in Chinese) 傅叁君, 高国生, 胡爱荣, 等.血清降钙素原和常用炎症指标联合CTP评分对慢加急性肝衰竭短期预后的预测价值[J].中国实用内科杂志, 2015, 35 (6) :519-521

[5]XU ZQ, XU L, LONG T, et al.Analysis of acute-on-chronic liver failure and chronic liver failure[J].Sino-foreign Med, 2009, 27 (9) :52. (in Chinese) 徐贞秋, 徐龙, 龙涛, 等.慢加亚急 (急) 性肝衰竭与慢性肝衰竭的临床分析[J].中外医疗, 2009, 27 (9) :52.

[6]BERNAL W, JALAN R, QUAGLIA A, et al.Acute-on-chronic liver failure[J].Lancet, 2015, 386 (10003) :1576-1587.

[7]YU FF, CAO WK, LI QW, et al.Expression of HBe Ag in liver failure and chronic hepatitis B[J].Tianjin Med, 2012, 40 (1) :34-36. (in Chinese) 于芳芳, 曹武奎, 李秋伟, 等.HBe Ag在肝衰竭和慢性乙型肝炎中的表达[J].天津医药, 2012, 40 (1) :34-36.

[8]CHANG TT, LIAW YF, WU SS, et al.Long-term entecavirtherapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B[J].Hepatology, 2010, 52 (3) :886-893.

[9]World Health Organization.Hepatitis B[EB/OL].[2012-04-15].http://www.who.int/mediacentre/Factsheets/fs204/en/.

[10] SARIN SK, KEDARISETTY CK, ABBAS Z, et al.Acute-onchronic liver failure:consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014[J].Hepatol Int, 2014, 8 (4) :453-471.

[11]LEI Q, MENG ZJ.Search progress of acute-on-chronic liver failure[J].China Med Herald, 2016, 13 (14) :45-48. (in Chinese) 雷青, 孟忠吉.慢加急性肝衰竭的研究进展[J].中国医药导报, 2016, 13 (14) :45-48.

[12]YANG X, ZHAO HX, XU QT.Clinical analysis of 101 cases with acute-on-chronic liver failur[J].J Clin Hepatol, 2009, 25 (5) :372-373. (in Chinese) 杨萱, 赵红霞, 许青田.慢加急性肝衰竭101例临床分析[J].临床肝胆病杂志, 2009, 25 (5) :372-373

[13]SARIN SK, KUMAR A, ALMEIDA JA, et al.Acute-on-chronic liver failure:consensus recommendations of the Asian pacific Association for the study of the liver (APASL) [J].Hepatol Int, 2009, 3 (1) :269-282.

[14]SARIN SK, KEDARISETTY CK, ABBAS Z, et al.Acute-onchronic liver failure:consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014[J].Hepatol Int, 2014, 8 (4) :453-471.

[15]OLSON JC, WENDON JA, KRAMER DJ.Intensive care of the patient with cirrhosis[J].Hepatology, 2011, 54 (5) :1864-1872.

[16] Canonic Study Investigators of the EASL-CLIF Consortium.Acute-on chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosi[J].Gastroenterology, 2013, 144 (7) :1426-1437.

[17] YANG FJ, PENG L, GAO ZL.New strategies and new progress in diagnosis and treatment of hepatitis B virus-related acute-onchronic liver failure[J].Chin J Clin Infect Dis, 2017, 2 (10) :101-106. (in Chinese) 杨方集, 彭亮, 高志良.乙型肝炎慢加急性肝衰竭诊疗的新策略与新进展[J].中华临床感染病杂志, 2017, 2 (10) :101-106.

[18]SHI H, LIN GL, PANG YJ, et al.Analysis of clinical characteristics and clinical classification of 220 cases of HBV-ACLF[J].Guangdong Med J, 2013, 34 (5) :744-746. (in Chinese) 时红, 林国莉, 庞艳娇, 等.HBV相关慢加急性肝衰竭220例临床特点分析及临床分型探讨[J].广东医学, 2013, 34 (5) :744-746.

[19]ZENG Z, HAN YK, GENG H, et al.Classification of chronic severe hepatitis[J].Chin J Exp Clin Virol, 2006, 20 (2) :53-55. (in Chinese) 曾珍, 韩玉坤, 耿华, 等.慢性重型肝炎分类的研究[J].中华实验和临床病毒学杂志, 2006, 20 (2) :53-55.

施引文献

资源附件(0)

访问统计